Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Surgery
Volume 2014, Article ID 456509, 4 pages
http://dx.doi.org/10.1155/2014/456509
Case Report

Giant Hepatic Carcinoid: A Rare Tumor with a Favorable Prognosis

1Department of Surgery, St Elizabeth Hospital, Avenue De Fré 206, 1180 Brussels, Belgium
2Department of Medicine, Clinique La Ramée, Avenue Boetendael 34, 1180 Brussels, Belgium

Received 1 November 2013; Accepted 31 December 2013; Published 9 February 2014

Academic Editors: D. J. Bentrem, A. Cho, and B. H. Lang

Copyright © 2014 Serge Landen et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. A. Maggard, J. B. O'Connell, and C. Y. Ko, “Updated population-based review of carcinoid tumors,” Annals of Surgery, vol. 240, no. 1, pp. 117–122, 2004. View at Publisher · View at Google Scholar · View at Scopus
  2. I. M. Modlin and A. Sandor, “An analysis of 8305 cases of carcinoid tumours,” Cancer, vol. 79, no. 4, pp. 813–829, 1997. View at Google Scholar
  3. C.-W. Lin, C.-H. Lai, C.-C. Hsu et al., “Primary hepatic carcinoid tumor: a case report and review of the literature,” Cases Journal, vol. 2, no. 1, article 90, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. Y.-Q. Huang, F. Xu, J.-M. Yang, and B. Huang, “Primary hepatic neuroendocrine carcinoma: clinical analysis of 11 cases,” Hepatobiliary and Pancreatic Diseases International, vol. 9, no. 1, pp. 44–48, 2010. View at Google Scholar · View at Scopus
  5. S. W. Fenwick, J. I. Wyatt, G. J. Toogood, and J. P. A. Lodge, “Hepatic resection and transplantation for primary carcinoid tumors of the liver,” Annals of Surgery, vol. 239, no. 2, pp. 210–219, 2004. View at Publisher · View at Google Scholar · View at Scopus
  6. G. Gravante, N. de Liguori Carino, J. Overton, T. M. Manzia, and G. Orlando, “Primary carcinoids of the liver: a review of symptoms, diagnosis and treatments,” Digestive Surgery, vol. 25, no. 5, pp. 364–368, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. P. Kongkam, M. Al-Haddad, S. Attasaranya et al., “EUS and clinical characteristics of cystic pancreatic neuroendocrine tumors,” Endoscopy, vol. 40, no. 7, pp. 602–605, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. H. Cerwenka, “Neuroendocrine liver metastases: contributions of endoscopy and surgery to primary tumor search,” World Journal of Gastroenterology, vol. 18, no. 10, pp. 1009–1014, 2012. View at Publisher · View at Google Scholar · View at Scopus
  9. J. A. Norton, R. S. Warren, M. G. Kelly et al., “Aggressive surgery for metastatic liver neuroendocrine tumors,” Surgery, vol. 134, no. 6, pp. 1057–1065, 2003. View at Publisher · View at Google Scholar · View at Scopus
  10. E. S. Glazer, J. F. Tseng, W. Al-Refaie et al., “Long-term survival after surgical management of neuroendocrine hepatic metastases,” HPB, vol. 12, no. 6, pp. 427–433, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. J. M. Sarmiento, F. G. Que, C. S. Grant et al., “Concurrent resections of pancreatic islet cell cancers with synchronous hepatic metastases: outcomes of an aggressive approach,” Surgery, vol. 132, no. 6, pp. 976–983, 2002. View at Publisher · View at Google Scholar · View at Scopus
  12. R. S. Chamberlain, D. Canes, K. T. Brown et al., “Hepatic neuroendocrine metastases: does intervention alter outcomes?” Journal of the American College of Surgeons, vol. 190, no. 4, pp. 432–445, 2000. View at Publisher · View at Google Scholar · View at Scopus
  13. S. Scigliano, R. Lebtahi, F. Maire et al., “Clinical and imaging follow-up after exhaustive liver resection of endocrine metastases: a 15-year monocentric experience,” Endocrine-Related Cancer, vol. 16, no. 3, pp. 977–990, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. J. M. Sarmiento, G. Heywood, J. Rubin, D. M. Ilstrup, D. M. Nagorney, and F. G. Que, “Surgical treatment of neuroendocrine metastases to the liver: a plea for resection to increase survival,” Journal of the American College of Surgeons, vol. 197, no. 1, pp. 29–37, 2003. View at Publisher · View at Google Scholar · View at Scopus
  15. J. Rosenau, M. J. Bahr, R. Von Wasielewski et al., “Ki67, e-cadherin, and p53 as prognostic indicators of long-term outcome after liver transplantation for metastatic neuroendocrine tumors,” Transplantation, vol. 73, no. 3, pp. 386–394, 2002. View at Google Scholar · View at Scopus
  16. Y. P. Le Treut, J. R. Delpero, B. Dousset et al., “Results of liver transplantation in the treatment of metastatic neuroendocrine tumors: a 31-case French multicentric report,” Annals of Surgery, vol. 225, no. 4, pp. 355–364, 1997. View at Publisher · View at Google Scholar · View at Scopus
  17. R. Gedaly, M. F. Daily, D. Davenport et al., “Liver transplantation for the treatment of liver metastases from neuroendocrine tumors: an analysis of the UNOS database,” Archives of Surgery, vol. 146, no. 8, pp. 953–958, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. Y. Mizuno, N. Ohkohchi, K. Fujimori et al., “Primary hepatic carcinoid tumor: a case report,” Hepato-Gastroenterology, vol. 47, no. 32, pp. 528–530, 2000. View at Google Scholar · View at Scopus
  19. C. D. Knox, C. D. Anderson, L. W. Lamps, R. B. Adkins, and C. W. Pinson, “Long-term survival after resection for primary hepatic carcinoid tumor,” Annals of Surgical Oncology, vol. 10, no. 10, pp. 1171–1175, 2003. View at Publisher · View at Google Scholar · View at Scopus
  20. N. de Liguori Carino, T. M. Manzia, L. Tariciotti, M. Berlanda, G. Orlando, and G. Tisone, “Liver transplantation in primary hepatic carcinoid tumor: case report and literature review,” Transplantation Proceedings, vol. 41, no. 4, pp. 1386–1389, 2009. View at Publisher · View at Google Scholar · View at Scopus
  21. D. Alekseev, A. Goralczyk, T. Lorf, G. Ramadori, and A. Obed, “Ten years survival with excellent outcome after living donor liver transplantation from 70 years old donor for primary hepatic neuroendocrine carcinoma: case report,” International Journal of Surgery Case Reports, vol. 3, no. 1, pp. 34–36, 2012. View at Publisher · View at Google Scholar · View at Scopus
  22. J. C. Arnold, J. G. O'Grady, G. L. Bird, R. Y. Calne, and R. Williams, “Liver transplantation for primary and secondary hepatic apudomas,” British Journal of Surgery, vol. 76, no. 3, pp. 248–249, 1989. View at Google Scholar · View at Scopus
  23. S. Andreola, L. Lombardi, R. A. Audisio et al., “A clinicopathologic study of primary hepatic carcinoid tumors,” Cancer, vol. 65, no. 5, pp. 1211–1218, 1990. View at Google Scholar · View at Scopus
  24. S. C. Krishnamurthy, V. Dutta, S. A. Pai et al., “Primary carcinoid tumor of the liver: report of four resected cases including one with gastrin production,” Journal of Surgical Oncology, vol. 62, no. 3, pp. 218–221, 1996. View at Google Scholar
  25. B. Wängberg, O. Nllsson, V. Johanson et al., “Somatostatin receptors in the diagnosis and therapy of neuroendocrine tumors,” Oncologist, vol. 2, no. 1, pp. 50–58, 1997. View at Google Scholar · View at Scopus
  26. A. Otte, J. Mueller-Brand, S. Dellas, E. U. Nitzsche, R. Herrmann, and H. R. Maecke, “Yttrium-90-labelled somatostatin-analogue for cancer treatment,” The Lancet, vol. 351, no. 9100, pp. 417–418, 1998. View at Publisher · View at Google Scholar · View at Scopus